Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Providence
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ProvidenceThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BaltimoreThis summary needs review. Please check the official study record and contact the research team for details.
In EvansThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
In San FranciscoThis study was terminated in Canada. It is testing Low-Dose Adjunctive Aripiprazole in the Treatment of Depression for depression in bipolarity.
In MontrealThis summary needs review. Please check the official study record and contact the research team for details.
In ZurichThis summary needs review. Please check the official study record and contact the research team for details.
In TaipeiThis summary needs review. Please check the official study record and contact the research team for details.
In New HavenThis summary needs review. Please check the official study record and contact the research team for details.
In DundalkThis study is looking at whether a digital support tool can help people with Attention Deficit Hyperactivity Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In VancouverThis summary needs review. Please check the official study record and contact the research team for details.
In PortlandHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.